Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples